This CRO (Contract Research Organization) has a 25+ year history and a dedicated team. Let's dive into the details: This business is focused on one key service: Offering full-spectrum clinical trial management, from pre-clinical to Phase 4. With their proprietary tech and seasoned team, they’ve built a strong reputation in the pharmaceutical and medical device industries. Here’s what sets them apart… Strategic presence. Prosoft Clinical serves clients across the U.S., Canada, and Europe, providing a diversified revenue stream. Their proprietary systems like eDC, IWRS, and AdaptIQ not only streamline trials but also have the potential for lucrative licensing opportunities. Plus… The owner is nearing retirement, making this an ideal acquisition opportunity. With a strong $10M backlog in signed contracts and $1M in new consulting revenue, this business is positioned for significant growth. But there’s more… Despite a dip during the COVID-19 pandemic, the company is on track to bounce back in 2024, potentially exceeding pre-pandemic revenue levels of $7M. The pipeline is strong, and with the right marketing strategy, the sky's the limit. What’s exciting? There’s untapped potential in licensing their tech and expanding into new therapeutic areas beyond their current focus. Plus, their client base, built largely on word of mouth, shows the trust and satisfaction they've earned over the years. Considering this? The current owners are committed to ensuring a smooth transition and are even open to staying on for a period to help scale the business. With the right vision, this could be a game-changer in the CRO industry. Enjoyed this breakdown? Drop a comment or DM me “clinical” and I’ll tell you how you can access this deal and others like it.

• The market: Pet safety & travel gear • The target: High-end pet owners & pros • The plan: Scale and grow with strategic support Here’s the breakdown: The pet industry is set to hit $500B by 2030. More pets = more safety concerns. This company? They’ve cornered the market on crash-tested pet transport products 🚗🐾 And the numbers? Revenue: $1.83M (2023) Earnings: $771K The kicker? They’re the exclusive importer for North America, so no real competition. But here’s where it gets interesting… Most sales (78%) come directly from consumers. What does that mean? Loyal, passionate customers + recurring revenue. And there’s room for more. Now think about this: The business doesn’t even advertise! They’ve grown purely through word-of-mouth. Imagine what would happen if you added digital marketing, partnerships, and new products. The opportunity is ripe for someone with the capital and vision to expand. The current owner? He’s looking for a strategic partner to take the business to the next level. So what’s the move? Step 1: acquire this unique business with solid financials. Step 2: implement a targeted marketing strategy and tap into new markets across the US, Canada, and beyond. Like this opportunity? Comment “pet” below for more info and deals like this every week!

You’d think it’s super complex. But it's actually pretty straightforward: A 100% remote marketing and consulting company for beauty professionals. Let’s look at the numbers: Revenue: 2022: $1.64M 2023: $2.08M 2024 forecast: $2.1M Earnings (SDE): 2022: $960K 2023: $810K 2024 forecast: $858K Why did earnings drop in 2023? Over-hiring. But that’s been fixed, so they’re back on track for 2024. 💪 Now, let’s talk about the asking price: Asking: $2.7M Multiple: 3.3x Here’s why it’s interesting: - 100% remote with 27 employees. - The GM handles 90% of day-to-day work. - Services are prepaid, and no single client brings more than 10% of the revenue. - Opportunities for growth? 1. Focus on client retention for recurring revenue. 2. Cut down the customer acquisition cost (currently at $1,562). 3. Expand into other niches outside of beauty. With the beauty industry set to hit $648B globally in 2024, this could be huge. 🌍 Like this deal? Comment “Beauty” below for more details and to get similar deals every week.

Sounds complex? It’s actually a straightforward opportunity. Let’s dive into the numbers: Revenue: 2022: $1.72M 2023: $3.11M 2024 (TTM): $3.97M 2025 (projected): $5M Earnings (Net Profit): 2022: $675K 2023: $1.54M 2024 (TTM): $1.93M 2025 (projected): $2.35M Asking Price: $8M Multiple: 4.1x This company has 30 skilled employees, and the best part? It’s fully remote! 🚀 The business has been growing thanks to its unique services for municipalities and has a solid pipeline of future projects. Risk to consider: 60% of revenue comes from one client—diversifying this will make the business more stable. Why I think this deal is promising: There’s huge room for growth—expanding into more cities, offering new AI-based services, and even entering the healthcare IT space. With the right strategy, revenue could skyrocket. 📈 Like this deal? Comment "IT" below to get more info on how to get this and other opportunities every week. 💼